P12 A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN(®) IN PATIENTS WITH BRAIN TUMOURS

INTRODUCTION: Oncolytic viruses preferentially replicate in, and kill cancerous cells. REOLYSIN(®) is a proprietary isolate of reovirus type 3 Dearing. In two trials using intralesional administration in gliomas and recurrent brain tumours, REOLYSIN(®) has been well tolerated, with early signs of ef...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jebar, A., West, E., Scott, K., Thomson, S., Corns, R., Mathew, R., SivaKumar, G., Coffey, M., Nuovo, G., Rose, A., Ralph, C., Twelves, C., Anthoney, A., Griffin, S., Short, S., Melcher, A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4200888/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou249.11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares